InNexus Biotechnology, Inc.
IXSBF
$0.00
$0.000.00%
OTC PK
| 03/31/2011 | 12/31/2010 | 09/30/2010 | 06/30/2010 | 03/31/2010 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 271.30K | 339.40K | 288.40K | 629.70K | 709.70K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 313.10K | 405.90K | 340.40K | 683.40K | 1.01M |
| Operating Income | -313.10K | -405.90K | -340.40K | -683.40K | -1.01M |
| Income Before Tax | -563.90K | -789.80K | -937.10K | -1.86M | -1.57M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -563.90K | -789.80K | -937.10K | -1.86M | -1.57M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -563.90K | -789.80K | -937.10K | -1.86M | -1.57M |
| EBIT | -313.10K | -405.90K | -340.40K | -683.40K | -1.01M |
| EBITDA | -197.50K | -316.20K | -247.60K | -580.70K | -905.20K |
| EPS Basic | 0.00 | -0.01 | -0.01 | -0.02 | -0.02 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | -0.01 | -0.01 |
| EPS Diluted | 0.00 | -0.01 | -0.01 | -0.02 | -0.02 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 163.45M | 146.79M | 129.19M | 111.73M | 102.24M |
| Average Diluted Shares Outstanding | 163.45M | 146.79M | 129.19M | 111.73M | 102.24M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |